NYSE · ATS
ATS financials
$18.30−2.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Mar 31 | Q4 '25 Mar 31 | Q4 '24 Mar 31 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Gross margin | — | — | — |
| Operating income | — | — | — |
| Net income | — | — | — |
| Net margin | — | — | — |
| Diluted EPS | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — |
| Free cash flow | — | — | — |
| Diluted shares | 98.1M | 98.0M | 98.6M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|
| Cash & equivalents | $205.0M | $157.0M | $125.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $921.7M | $1.09B | $869.7M |
| Total assets | $3.12B | $3.21B | $3.02B |
| Total liabilities | $1.84B | $2.02B | $1.78B |
| Shareholders' equity | $1.28B | $1.19B | $1.25B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology